Can repeat laser eye treatment keep glaucoma in check?

NCT ID NCT05159960

ENROLLING_BY_INVITATION Disease control Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at the best way to repeat a laser treatment called SLT for people with open-angle glaucoma or high eye pressure. Researchers will compare different treatment methods in 400 participants who were already in an earlier SLT trial. The goal is to see how well repeat SLT lowers eye pressure and how long the effect lasts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Selective laser trabeculoplasty (SLT) with pilocarpine and tetracaine eye drops
What this could lead to: If successful, this could establish the best way to repeat SLT to control eye pressure and delay the need for more invasive treatments.
What could go wrong: This is an observational extension of an earlier trial, not a new treatment test. Results may not apply to all glaucoma patients, and repeat SLT may not work as well as the first time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, OPEN-ANGLE OCULAR HYPERTENSION PSEUDOEXFOLIATION GLAUCOMA

Contacts and locations

Locations

Department of Ophthalmology, NU Hospital Group

Uddevalla, Västra Götaland County, 45153, Sweden
Department of Ophthalmology, Skaraborg Hospital

Skövde, Västra Götaland County, 54142, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.